Tuesday, April 16, 2024 4/16/2024

Prolonged Daily Fasting As a Viable Alternative to Caloric Restriction in At-Risk Obese Humans

Award Number: R01DK124484
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

ABSTRACT Obesity is reaching epidemic proportions, affecting 36% of the adult population in the United States. The first line of obesity treatment is caloric restriction (CR), although recidivism is common. Therefore, alternative options to CR need to be considered. As humans are constantly eating, daily prolonged fasting through time restricted eating (TRE) shifts the paradigm in obesity treatment. In humans, TRE imposes a daily fasting period (14-16 hours) by only allowing food intake during fixed daily eating window (~8 to 10 hours). By implementing TRE in a pilot study of healthy, overweight humans for 12 weeks, we found that TRE reduced weight and fat mass, with greater restriction of the eating window resulting in greater loss of fat mass and visceral fat. As actigraphy-measured physical activity and sleep measures did not change, we propose that prolonged fasting is the primary mediator of TRE- associated changes. We hypothesize that TRE with ad libitum intake presents a highly viable alternative to CR in reducing weight, fat mass and improving insulin sensitivity, as daily prolonged fasting reduces caloric intake and enhances metabolic flexibility—the adaptability of fuel selection given ambient fuel exposure. We will recruit obese, insulin-resistant humans with an eating window =14 hours, who will be randomized to 1 of 3 groups: 1) TRE (8 hour eating window) with ad libitum intake, 2) CR with 15% reduction of caloric intake, 3) non-TRE with ad libitum intake for 12 weeks. Our specific aims include the following: Aim#1: Evaluate the effect of TRE with ad libitum intake on weight and body composition. Aim#2: Assess the effect of TRE with ad libitum intake on caloric balance. Aim#3: Assess the effect of TRE with ad libitum intake on metabolic flexibility. This project’s objective is to examine the role of prolonged fasting in TRE-associated metabolic changes. The scientific premise is that prolonged fasting associated with TRE reduces caloric intake and enhances metabolic flexibility—the adaptability of fuel selection given ambient fuel exposure. Therefore, TRE will enhance fat oxidation in the fasting state and carbohydrate oxidation in the fed state, to be more metabolically advantageous than CR without prolonged fasting. The significance is establishing TRE as a practical means of implementing prolonged fasting on a large scale and a viable alternative to CR without prolonged fasting, thereby transforming the treatment of obesity


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $669,417 )
2023	2023	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE # 224	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	4	1/12/2023	NON-COMPETING CONTINUATION	$669,417
														Subtotal = $669,417

Issue Date FY: 2022 ( Subtotal = $674,558 )
2022	2022	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE # 224	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	1/18/2022	NON-COMPETING CONTINUATION	$607,103
2022	2022	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE # 224	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	3	3/29/2022	NON-COMPETING CONTINUATION	$67,455
														Subtotal = $674,558

Issue Date FY: 2021 ( Subtotal = $684,484 )
2021	2021	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE # 224	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	2	2/3/2021	NON-COMPETING CONTINUATION	$68,450
2021	2021	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE # 224	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	12/11/2020	NON-COMPETING CONTINUATION	$616,034
														Subtotal = $684,484

Issue Date FY: 2020 ( Subtotal = $696,191 )
2020	2020	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE # 224	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/17/2020	NEW	$696,191
														Subtotal = $696,191

Grand Total All Awards = $2,724,650

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Prolonged Daily Fasting As a Viable Alternative to Caloric Restriction in At-Risk Obese Humans

Award Number: R01DK124484

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer